The β-human chorionic gonadotropin-related peptide LQGV reduces mortality and inflammation in a murine polymicrobial sepsis model

Critical Care Medicine

Volumn 39, Issue 1, 2011, Pages 126-134

  Van Den Berg, Jan Willem ^a   Dik, Willem A ^a   Van Der Zee, Marten ^a   Bonthuis, Fred ^a   Van Holten Neelen, Conny ^a   Dingjan, Gemma M ^a   Benner, Robbert ^a   Ijzermans, Jan N M ^a   Khan, Nisar A ^a   De Bruin, Ron W F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CLP; hCG; inflammation; LQGV; sepsis; therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LEUCYLGLUTAMINYLVALYLGLYCINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TETRAPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CECUM; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RESPONSE; ENTERITIS; FLUID RESUSCITATION; LIGATION; LUNG; MALE; MONOTHERAPY; MORTALITY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; SEPSIS; SURVIVAL RATE; TISSUE LEVEL; TRANSCRIPTION INITIATION;

EID: 78651251894     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fa3a93     Document Type: Article

References (53)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310
3. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-1250
4. Haveman JW, Muller Kobold AC, Tervaert JW, et al: The central role of monocytes in the pathogenesis of sepsis: Consequences for immunomonitoring and treatment. Neth J Med 1999;55:132-141
5. Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev 2008;8:776-787
6. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-1128
7. Hotchkiss RS, Coopersmith CM, McDunn JE, et al: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009;15: 496-497
8. Russell JA: Management of sepsis. N Engl J Med 2006;355:1699-1713
9. Chaouat G: Innately moving away from the Th1/Th2 paradigm in pregnancy. Clin Exp Immunol 2003;131:393-395
10. McCracken SA, Gallery E, Morris JM: Pregnancy- specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success. J Immunol 2004;172:4583-4591
11. Kaaja RJ, Greer IA: Manifestations of chronic disease during pregnancy. JAMA 2005;294: 2751-2757
12. Han T: Human chorionic gonadotropin: Its inhibitory effect on cell-mediated immunity in vivo and in vitro. Immunology 1975;29: 509-515
13. Nepomnaschy PA, Weinberg CR, Wilcox AJ, et al: Urinary hCG patterns during the week following implantation. Hum Reprod 2008;23:271-277
14. Cole LA, Kardana A, Ying FC, et al: The biological and clinical significance of nicks in human chorionic gonadotropin and its free beta-subunit. Yale J Biol Med 1991;64: 627-637
15. Khan NA, Khan A, Savelkoul HF, et al: Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol 2001;62: 1315-1323
16. van den Berg HR, Khan NA, van der Zee M, et al: Synthetic oligopeptides related to the [beta]- subunit of human chorionic gonadotropin attenuate inflammation and liver damage after (trauma) hemorrhagic shock and resuscitation. Shock 2009;31:285-291
17. Khan NA, Vierboom MP, van Holten-Neelen C, et al: Mitigation of septic shock in mice and rhesus monkeys by human chorionic gonadotrophin-related oligopeptides. Clin Exp Immunol 2010;160:466-478
18. van der Zee M, Dik WA, Kap YS, et al: Synthetic human chorionic gonadotropinrelated oligopeptides impair early innate immune responses to Listeria monocytogenes in mice. J Infect Dis 2010;201:1072-1080
19. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-871
20. Tracey KJ, Fong Y, Hesse DG, et al: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-664
21. Remick D, Manohar P, Bolgos G, et al: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995;4:89-95
22. Eskandari MK, Bolgos G, Miller C, et al: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992;148:2724-2730
23. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996;334:1697-1702
24. Reinhart K, Menges T, Gardlund B, et al: Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 2001;29:765-769
25. Buras JA, Holzmann B, Sitkovsky M: Animal models of sepsis: Setting the stage. Nat Rev Drug Discov 2005;4:854-865
26. Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007;81: 137-143
27. Rittirsch D, Huber-Lang MS, Flierl MA, et al: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009;4:31-36
28. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock-A review of laboratory models and a proposal. J Surg Res 1980;29:189-201
29. Khan NA, Susa D, van den Berg JW, et al: Amelioration of renal ischaemia-reperfusion injury by synthetic oligopeptides related to human chorionic gonadotropin. Nephrol Dial Transplant 2009;24:2701-2708
30. Osuchowski MF, Connett J, Welch K, et al: Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009;37:1567-1573
31. van Steensel L, Paridaens D, Dingjan G, et al: Platelet-derived growth factor-BB: A stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 2010;51:1002-1007
32. Remick DG, Bolgos GR, Siddiqui J, et al: Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002;17:463-467
33. Remick DG, Bolgos G, Copeland S, et al: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 2005;73:2751-2757
34. Osuchowski MF, Welch K, Siddiqui J, et al: Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006;177:1967-1974
35. Riese J, Denzel C, Zowe M, et al: Secretion of IL-6, monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha, and TNFalpha by cultured intact human peritoneum. Eur Surg Res 1999;31:281-288
36. Kato S, Yuzawa Y, Tsuboi N, et al: Endotoxininduced chemokine expression in murine peritoneal mesothelial cells: The role of Tolllike receptor 4. J Am Soc Nephrol 2004;15:1289-1299
37. Mantovani A, Bussolino F, Dejana E: Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591-2599
38. Goss CH, Brower RG, Hudson LD, et al: Incidence of acute lung injury in the United States. Crit Care Med 2003;31:1607-1611
39. Bedirli A, Kerem M, Pasaoglu H, et al: Betaglucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis. Shock 2007;27:397-401
40. Shen L, Mo H, Cai L, et al: Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock 2009;31:500-506
41. Christman JW, Sadikot RT, Blackwell TS: The role of nuclear factor-kappa B in pulmonary diseases. Chest 2000;117:1482-1487
42. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866
43. Maack T, Johnson V, Kau ST, et al: Renal filtration, transport, and metabolism of lowmolecular- weight proteins: A review. Kidney Int 1979;16:251-270
44. Kaczorowski DJ, Mollen KP, Edmonds R, et al: Early events in the recognition of danger signals after tissue injury. J Leukoc Biol 2008;83:546-552
45. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006;124:783-801
46. Kawai T, Akira S: Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007;13:460-469
47. Williams DL, Ha T, Li C, et al: Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 2003;31:1808-1818
48. McConnell KW, McDunn JE, Clark AT, et al: Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses. Crit Care Med 2010;38: 223-241
49. van der Zee M, van den Berg JW, van Holten- Neelen C, et al: The-human chorionic gonadotropin- related peptide LQGV exerts antiinflammatory effects through activation of the adrenal gland and glucocorticoid receptor in C57BL/6 mice. J Immunol 2010, in press
50. Villa P, Sartor G, Angelini M, et al: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995;2:549-553
51. Gadina M, Bertini R, Mengozzi M, et al: Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid- sensitive and glucocorticoidresistant models of endotoxic shock. J Exp Med 1991; 173:1305-1310
52. Riedemann NC, Neff TA, Guo RF, et al: Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170:503-507
53. Newcomb D, Bolgos G, Green L, et al: Antibiotic treatment influences outcome in murine sepsis: Mediators of increased morbidity. Shock 1998; 10:110-117